Immunochemical and tissue analysis of protease generated neoepitopes of BM-40 (osteonectin, SPARC) which are correlated to a higher affinity binding to collagens

Matrix Biology

Volumn 18, Issue 5, 1999, Pages 499-508

  Sasaki, Takako ^a   Miosge, Nicolai ^b   Timpl, Rupert ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; EPITOPE; METALLOPROTEINASE; OSTEONECTIN; PROTEINASE;

ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; RADIOIMMUNOASSAY; TUMOR CELL;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY SPECIFICITY; BINDING SITES; COLLAGEN; CROSS REACTIONS; ENDOPEPTIDASES; EPITOPES; EXTRACELLULAR MATRIX; HUMANS; IMMUNOCHEMISTRY; MALE; MICE; NEOPLASMS, EXPERIMENTAL; OSTEONECTIN; PROTEIN BINDING; RABBITS; RADIOIMMUNOASSAY;

ORYCTOLAGUS CUNICULUS;

EID: 0032704239     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(99)00041-4     Document Type: Article

References (51)

1. Aeschlimann D., Kaupp O., Paulsson M. Transglutaminase-catalyzed matrix cross-linking in differentiating cartilage: identification of osteonectin as a major glutaminyl substrate. J. Cell Biol. 129:1995;881-892.
2. Basbaum C.B., Werb Z. Focalized proteolysis: spatial and temporal regulation of extracellular matrix at the cell surface. Curr. Opin. Cell Biol. 8:1996;731-738.
3. Bassuk J.A., Iruela-Arispe M.-L., Lane T.F., Benson J.M., Berg R.A., Sage E.H. Molecular analysis of chicken embryo SPARC (osteonectin). Eur. J. Biochem. 218:1993;117-127.
4. Bossard M.J., Tomaszek T.A., Thompson S.K. et al. Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification. J. Biol. Chem. 271:1996;12517-12524.
5. DeMey J., Moermans N., Geuens G., Nydens R., De Brabander M. High resolution light and electron microscopic localization of tubulin with the IGS (immuno gold staining) method. Cell Biol. Int. Rep. 5:1981;889-899.
6. Flannery C.R., Lark M.W., Sandy J.D. Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. Evidence for proteolysis at this site in vivo in human articular cartilage. J. Biol. Chem. 267:1992;1008-1014.
7. Fosang A.J., Neame P.J., Last K., Hardingham T.E., Murphy G., Hamilton J.A. The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases and cathepsin B. J. Biol. Chem. 267:1992;19470-19474.
8. Fosang A.J., Last K., Knäuper V. et al. Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain. Biochem. J. 295:1993;273-276.
9. Fosang A.J., Last K., Neame P.J. et al. Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan. Biochem. J. 304:1994;347-351.
10. Fosang A.J., Last K., Gardiner P., Jackson D.C., Brown L. Development of a cleavage site-specific monoclonal antibody for detecting metalloproteinase-derived aggrecan fragments: detection of fragments in human synovial fluid. Biochem. J. 310:1995;337-343.
11. Fosang A.J., Last K., Knäuper V., Murphy G., Neami P.J. Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett. 380:1996;17-20.
12. Fosang A.J., Last K., Maciewicz R.A. Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinases and aggrecanase activities can be independent. J. Clin. Invest. 98:1996;2292-2299.
13. Frens G. Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nat. Phys. Sci. 241:1973;20-22.
14. Herken R., Manshausen B., Fussek M., Bonatz G. Methodological dependence in the ultrastructural immunolocalizations of laminin in tubular basement membranes of the mouse kidney. Histochemistry. 87:1987;59-64.
15. Hohenadl C., Mann K., Mayer U., Timpl R., Paulsson M., Aeschlimann D. Two adjacent N-terminal glutamines of BM-40 (osteonectin, SPARC) act as amine acceptor sites in transglutaminasec-catalyzed modification. J. Biol. Chem. 270:1995;23415-23420.
16. 2+-binding module in BM-40. Nat. Struct. Biol. 3:1996;67-73.
17. Hohenester E., Maurer P., Timpl R. Crystal structure of a pair of follistatin-like and EF-hand calcium-binding domains in BM-40. EMBO J. 16:1997;3778-3786.
18. Hughes C.E., Caterson B., White R.J., Roughley P.J., Mort J.S. Monoclonal antibodies recognizing protease-generated neoepitopes from cartilage proteoglycan degradation. Application to studies of human link protein cleavage by stromelysin. J. Biol. Chem. 267:1992;16011-16014.
19. Hughes C., Caterson B., Fosang A.J., Roughly P.J., Mort J.S. Monoclonal antibodies that specifically recognize neoepitope sequences generated by 'aggrecanase' and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro. Biochem J. 305:1995;799-804.
20. Iruela-Arispe M.L., Lane T.F., Redmond D. et al. Expression of SPARC during development of the chicken chorioallantoic membrane: evidence for regulated proteolysis in vivo. Mol. Biol. Cell. 6:1995;327-343.
21. Iruela-Arispe M.L., Vernon R.B., Wu R., Jaenisch R., Sage E.H. Type I collagen-deficient mov-13 mice do not retain SPARC in the extracellular matrix: implications for fibroblast function. Dev. Dyn. 207:1996;171-183.
22. Kupprion C., Motamed K., Sage E.H. SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. J. Biol. Chem. 273:1998;29635-29640.
23. Lane T.F., Sage E.H. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J. 8:1994;163-173.
24. Lankat-Buttgereit B., Mann K., Deutzmann R., Timpl R., Krieg T. Cloning and complete amino acid sequences of human and murine basement membrane protein BM-40 (SPARC, osteonectin). FEBS Lett. 236:1988;352-356.
25. Lark M.W., Williams H., Hoernner L.A. et al. Quantification of a matrix metalloproteinase-generated aggrecan G1 fragment using monospecific anti-peptide serum. Biochem. J. 307:1995;245-252.
26. Mann K., Deutzmann R., Paulsson M., Timpl R. Solubilization of protein BM-40 from a basement membrane tumor with chelating agents and evidence for its identity with osteonectin and SPARC. FEBS Lett. 218:1987;167-172.
27. Maurer P., Hohenadl C., Hohenester E., Göhring W., Timpl R., Engel J. The C-terminal portion of BM-40 (SPARC/osteonectin) is an autonomously folding and crystallisable domain that binds calcium and collagen IV. J. Mol. Biol. 253:1995;347-357.
28. Maurer P., Göhring W., Sasaki T., Mann K., Timpl R., Nischt R. Recombinant and tissue-derived mouse BM-40 bind to several collagen types and have increased affinities after proteolytic activation. Mol. Life Sci. 53:1997;478-484.
29. Mayer U., Mann K., Timpl R., Murphy G. Sites of nidogen cleavage by proteases involved in tissue homeostasis and remodelling. Eur. J. Biochem. 217:1993;877-884.
30. Mecham R.P., Broekelmann T.J., Fliszar C.J., Shapiro S.D., Welgus H.G., Senior R.M. Elastin degradation by matrix metalloproteinases. Cleavage site specificity and mechanisms of elastolysis. J. Biol. Chem. 272:1997;18071-18076.
31. Mort J.S., Magny M.-C., Lee E.R. Cathepsin B: an alternative protease for the generation of an aggrecan 'metalloproteinase' cleavage neoepitope. Biochem. J. 335:1998;491-494.
32. Nguyen Q., Murphy G., Hughes C.E., Mort J.S., Roughly P.J. Matrix proteinases cleave at two distinct sites on human cartilage link protein. Biochem. J. 295:1993;595-598.
33. Nischt R., Pottgiesser J., Krieg T., Mayer U., Aumailley M., Timpl R. Recombinant expression and properties of the human calcium-binding extracellular matrix protein BM-40. Eur. J. Biochem. 200:1991;529-536.
34. Otsuka K., Yao K.L., Wasi S. et al. Biosynthesis of osteonectin by fetal porcine calvarial cells in vitro. J. Biol. Chem. 259:1984;9805-9812.
35. Paulsson M., Aumailley M., Deutzmann R., Timpl R., Beck K., Engel J. Laminin-nidogen complex: extraction with chelating agents and structural characterization. Eur. J. Biochem. 166:1987;11-19.
36. Prockop D.J., Sieron A.L., Li S.-W. Procollagen N-proteinase and procollagen C-proteinase. Two unusual metalloproteinases that are essential for procollagen processing probably have important roles in development and cell signalling. Matrix Biol. 16:1998;399-408.
37. Sage E.H. Terms of attachment: SPARC and turmorigenesis. Nat. Med. 3:1997;144-146.
38. Sasaki T., Mann K., Murphy G., Chu M.-L., Timpl R. Different susceptibilities of fibulin-1 and fibulin-2 to cleavage by matrix metalloproteinases and other tissue proteases. Eur. J. Biochem. 240:1996;427-434.
39. Sasaki T., Wiedemann H., Matzner M., Chu M.-L., Timpl R. Expression of fibulin-2 by fibroblasts and deposition with fibronectin into a fibrillar matrix. J. Cell Sci. 109:1996;2895-2904.
40. Sasaki T., Göhring W., Mann K. et al. Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens. J. Biol. Chem. 272:1997;9237-9243.
41. Sasaki T., Fukai N., Mann K., Göhring W., Olsen B.R., Timpl R. Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin. EMBO J. 17:1998;4249-4256.
42. Sasaki T., Hohenester E., Göhring W., Timpl R. Crystal structure and mapping by site-directed mutagenesis of the collagen epitope of an activated form of BM-40/SPARC/osteonectin. EMBO J. 17:1998;1625-1634.
43. Shapiro S.D. Matrix metalloproteinase degradation of extracellular matrix: biological consequences. Curr. Opin. Cell Biol. 10:1998;602-608.
44. Singer I.I., Kawka D.W., Bayne E.K. et al. VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis. J. Clin. Invest. 95:1995;2178-2186.
45. Siri A., Knäuper V., Veirana N., Caocci F., Murphy G., Zardi L. Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases. J. Biol. Chem. 270:1995;8650-8654.
46. Slot J.W., Geuze H.J. Sizing of protein A-colloidal gold probes for immunoelectron microscopy. J. Cell Biol. 90:1981;533-536.
47. Timpl R. Antibodies to collagens and procollagens. Methods Enzymol. 82:1982;472-498.
48. Tortorella M.D., Burn T.C., Pratta M.A. et al. Purification and cloning of aggrecanase-1: A member of the ADAMTS family of proteins. Science. 284:1999;1664-1666.
49. Tyree B. The partial degradation of osteonectin by a bone-derived metalloprotease enhances binding to type I collagen. J. Bone Mineral Res. 4:1989;877-883.
50. von Bredow D.C., Nagle R.B., Bowden G.T., Cress A.E. Degradation of fibronectin fibrils by matrilysin and characterization of degradation products. Exp. Cell Res. 221:1995;83-91.
51. Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell. 91:1997;439-442.